Consequently, there is an urgent medical need to unravel the molecular function of TFE3-fusion proteins to comprehensively understand the molecular basis of tRCC and identify novel therapeutic targets. Here, TFE3 is linked to renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.